Plaintiffs in Taxotere eye injury litigation say their lawsuits are justified in moving forward because Sanofi failed to put adequate tear duct injury warnings on the label.
Sanofi has filed a motion to dismiss Taxotere excessive tearing lawsuits on the basis of a label warning critics have said is inadequate.
A Taxotere lawsuit filed by a Virginia woman claims she suffered tear duct obstruction and required painful surgery after using Taxotere for only two months.
A federal appeals court has overturned a defense verdict in the first Taxotere hair loss bellwether trial, calling for a new trial to be held.
Taxotere eye injury lawsuits filed in federal courts nationwide will be consolidated and centralized in the U.S. District Court for the Eastern District of Louisiana for pretrial proceedings.
A panel of judges has agreed to consider consolidating all Taxotere eye injury lawsuits filed in federal courts before one judge as part of a second multidistrict litigation involving the…
Sanofi faces several new lawsuits claiming Taxotere eye problems resulted in vision damage and vision loss, which may be folded together into a new MDL for the breast cancer drug.
A second Taxotere bellwether trial over permanent hair loss has resulted in a defense verdict.
This week, Sanofi announced intentions to re-launch Zantac under the name Zantac 360, which will use the active ingredient from Pepcid instead of ranitidine, which has been linked to increased…
Three Taxotere hair loss lawsuits have been selected to serve as potential fourth bellwether trials over claims the chemotherapy drug's manufacturers failed to warn patients of the risk of permanent…